CANEPA, MARCO
 Distribuzione geografica
Continente #
EU - Europa 12.712
AS - Asia 1.533
NA - Nord America 710
SA - Sud America 154
AF - Africa 44
OC - Oceania 8
Continente sconosciuto - Info sul continente non disponibili 1
Totale 15.162
Nazione #
IT - Italia 12.446
US - Stati Uniti d'America 674
SG - Singapore 623
CN - Cina 377
VN - Vietnam 301
FR - Francia 123
BR - Brasile 97
HK - Hong Kong 72
DE - Germania 33
FI - Finlandia 31
AR - Argentina 29
GB - Regno Unito 26
IN - India 25
IQ - Iraq 22
JP - Giappone 20
BD - Bangladesh 18
MX - Messico 17
PK - Pakistan 9
CH - Svizzera 8
EC - Ecuador 8
RU - Federazione Russa 8
CA - Canada 7
ID - Indonesia 7
MA - Marocco 7
NL - Olanda 7
PH - Filippine 7
TN - Tunisia 7
UZ - Uzbekistan 7
ZA - Sudafrica 7
CL - Cile 6
IE - Irlanda 6
KR - Corea 6
AU - Australia 5
EG - Egitto 5
ES - Italia 5
PY - Paraguay 5
TH - Thailandia 5
TR - Turchia 5
AZ - Azerbaigian 4
UA - Ucraina 4
CO - Colombia 3
CR - Costa Rica 3
DO - Repubblica Dominicana 3
JO - Giordania 3
KE - Kenya 3
MY - Malesia 3
NP - Nepal 3
OM - Oman 3
PA - Panama 3
VE - Venezuela 3
AM - Armenia 2
BE - Belgio 2
CM - Camerun 2
CZ - Repubblica Ceca 2
IR - Iran 2
NZ - Nuova Zelanda 2
SA - Arabia Saudita 2
UY - Uruguay 2
ZW - Zimbabwe 2
AE - Emirati Arabi Uniti 1
AL - Albania 1
AT - Austria 1
BA - Bosnia-Erzegovina 1
BH - Bahrain 1
BO - Bolivia 1
CG - Congo 1
DJ - Gibuti 1
DK - Danimarca 1
DZ - Algeria 1
ET - Etiopia 1
FJ - Figi 1
HN - Honduras 1
HU - Ungheria 1
IL - Israele 1
JM - Giamaica 1
KH - Cambogia 1
KW - Kuwait 1
MN - Mongolia 1
MZ - Mozambico 1
NA - Namibia 1
NE - Niger 1
NG - Nigeria 1
NI - Nicaragua 1
NO - Norvegia 1
PL - Polonia 1
PT - Portogallo 1
RO - Romania 1
RW - Ruanda 1
SE - Svezia 1
SK - Slovacchia (Repubblica Slovacca) 1
SN - Senegal 1
TG - Togo 1
TW - Taiwan 1
XK - ???statistics.table.value.countryCode.XK??? 1
Totale 15.162
Città #
Genova 6.227
Genoa 4.017
Vado Ligure 1.043
Rapallo 1.034
Singapore 289
San Jose 251
Lauterbourg 114
Ashburn 112
Ho Chi Minh City 102
Council Bluffs 81
Hong Kong 66
Beijing 60
Hanoi 58
New York 42
Bordighera 33
Helsinki 28
Santa Clara 25
Frankfurt am Main 20
Tokyo 17
Da Nang 16
Mexico City 15
Baghdad 12
Haiphong 11
St Louis 10
Zurich 8
Milan 7
Orem 7
São Paulo 7
Chennai 6
Hải Dương 6
Los Angeles 6
Quảng Ngãi 6
Rome 6
Tianjin 6
Biên Hòa 5
Chicago 5
Dublin 5
Quito 5
Tashkent 5
Cardiff 4
Dallas 4
Des Moines 4
Dhaka 4
Guangzhou 4
Madrid 4
Naples 4
Nuremberg 4
Paris 4
Phủ Lý 4
Sydney 4
Amman 3
Asunción 3
Baku 3
Boardman 3
Buenos Aires 3
Bắc Ninh 3
Catania 3
City of London 3
Florianópolis 3
Hangzhou 3
Itajaí 3
Karachi 3
Lappeenranta 3
Manchester 3
Mumbai 3
Nanchang 3
Nha Trang 3
Panama City 3
Ravenna 3
Ribeirão Preto 3
Thái Bình 3
Tunis 3
Amsterdam 2
Basingstoke 2
Belo Horizonte 2
Bologna 2
Brugherio 2
Caxias do Sul 2
Cesena 2
Changsha 2
Chittagong 2
Ciserano 2
Curitiba 2
Denver 2
Durban 2
Gujranwala 2
Hamburg 2
Huntington 2
Istanbul 2
Johannesburg 2
Kingston 2
Kuala Lumpur 2
London 2
Lấp Vò 2
Macapá 2
Maidstone 2
Medan 2
Montreal 2
Mosul 2
Muscat 2
Totale 13.939
Nome #
5-fluorouracil causes endothelial cell senescence: Potential protective role of glucagon-like peptide 1 263
Neurohormonal activation and pharmacological inhibition in pulmonary arterial hypertension and related right ventricular failure 228
Doxorubicin impairs the insulin-like growth factor-1 system and causes insulin-like growth factor-1 resistance in cardiomyocytes 224
The human amniotic fluid stem cell secretome effectively counteracts doxorubicin-induced cardiotoxicity 218
Using unsupervised learning to determine risk level for left ventricular diastolic dysfunction2014 IEEE International Conference on Bioinformatics and Biomedicine (BIBM) 203
Distinguishing ventricular septal bulge versus hypertrophic cardiomyopathy in the elderly 203
Characteristics of current heart failure patients admitted to internal medicine vs. cardiology hospital units: the VASCO study 202
E / e' ratio and outcome prediction in hypertrophic cardiomyopathy: The influence of outflow tract obstruction 197
Data regarding the effects of thrombin and dabigatran-inhibited thrombin on protease-activated receptor 1 and activation of human atrial fibroblasts 197
Correlation between thoracic aorta 18F-natrium fluoride uptake and cardiovascular risk 193
Characteristics, treatments and 1-year prognosis of hospitalized and ambulatory heart failure patients with chronic obstructive pulmonary disease in the European Society of Cardiology Heart Failure Long-Term Registry 191
Thrombin induces protease-activated receptor 1 signaling and activation of human atrial fibroblasts and dabigatran prevents these effects 188
Clinical characteristics and prognostic impact of atrial fibrillation in patients with chronic heart failure 186
T1 mapping with cardiovascular magnetic resonance: An emerging clinical biomarker 185
Prevalent cardiac, renal and cardiorenal damage in patients with advanced abdominal aortic aneurysms 184
Arterial stiffness and vitamin D levels: the Baltimore longitudinal study of aging. 177
Testosterone Antagonizes Doxorubicin-Induced Senescence of Cardiomyocytes 177
[Cardiac cell therapy: the puzzle is waiting to be solved] 176
Recurrent and residual shunts after patent foramen ovale closure: Results from a long-term transcranial doppler study 173
Causes and impact on survival of underuse of angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers in heart failure 170
Cancer diagnosis in patients with heart failure: Epidemiology, clinical implications and gaps in knowledge 167
Short-term effect of rosuvastatin treatment on arterial stiffness in individuals with newly-diagnosed heterozygous familial hypercholesterolemia 165
Clinical Outcomes in Patients With Nonobstructive, Labile, and Obstructive Hypertrophic Cardiomyopathy 165
Frequency, predictors and prognostic impact of implantable cardioverter defibrillator shocks in a primary prevention population with heart failure and reduced ejection fraction 165
Early contribution of arterial wave reflection to left ventricular relaxation abnormalities in a community-dwelling population of normotensive and untreated hypertensive men and women. 163
The relationship between visceral adiposity and left ventricular diastolic function: results from the Baltimore Longitudinal Study of Aging. 163
Methods, accuracy and clinical implications of atrial fibrillation detection by cardiac implantable electronic devices 162
Serial Troponin for Early Detection of Nivolumab Cardiotoxicity in Advanced Non-Small Cell Lung Cancer Patients 160
Amyloid Cardiomyopathy in the Rare Transthyretin Tyr78Phe Mutation 156
Vitamin D modulates the association of circulating insulin-like growth factor-1 with carotid artery intima-media thickness 151
Prevalence and Undertreatment of Prothrombotic Risk in Advanced Forms of Liver Disease 151
What can we learn from pulmonary function testing in heart failure? 148
Longitudinal trajectories of arterial stiffness and the role of blood pressure: the Baltimore Longitudinal Study of Aging. 147
Performance of Prognostic Risk Scores in Chronic Heart Failure Patients Enrolled in the European Society of Cardiology Heart Failure Long-Term Registry 146
The association between leptin and depressive symptoms is modulated by abdominal adiposity. 144
ECHOCARDIOGRAPHIC AND CLINICAL CORRELATES OF SPECIFIC EARLY REPOLARIZATION SUBTYPES ON ELECTROCARDIOGRAM 144
Impact of peak provoked left ventricular outflow tract gradients on clinical outcomes in hypertrophic cardiomyopathy 141
Comparison of Outcomes in Patients With Nonobstructive, Labile-Obstructive, and Chronically Obstructive Hypertrophic Cardiomyopathy 141
Prevalence and Prognostic Impact of Chronic Obstructive Pulmonary Disease in Patients with Chronic Heart Failure: Data from the GISSI-HF Trial 140
Real-world versus trial patients with transthyretin amyloid cardiomyopathy 140
GENDER DIFFERENCES IN EARLY MANIFESTATIONS OF ARTERIAL STIFFNESS: RESULTS FROM THE SARDINIA PROJECT 139
Contribution of central adiposity to left ventricular diastolic function (from the Baltimore Longitudinal Study of Aging). 138
Linking Heart Failure to Cancer 138
Multiparametric vs. Inferior Vena Cava-Based Estimation of Right Atrial Pressure 136
Long-Term Left Ventricular Remodeling of Patients With Hypertrophic Cardiomyopathy 135
Doxorubicin impairs the insulin-like growth factor-1 axis in H9c2 cells 134
The Relationship Between Brain–Heart Autonomic Signaling and Aging: A Gender-Specific Longitudinal Perspective from the Baltimore Longitudinal Study on Aging 133
Comparison of clinical presentation, left ventricular morphology, hemodynamics, and exercise tolerance in obese versus nonobese patients with hypertrophic cardiomyopathy. 132
Diagnostic value of ischemia severity at myocardial perfusion imaging in elderly persons with suspected coronary disease 132
Role of bone mineral density in the inverse relationship between body size and aortic calcification: Results from the Baltimore Longitudinal Study of Aging. 131
Time for an "Atrial-Watchful" Approach for Heart Failure Patients With a Cardiac Implantable Electronic Device 131
Cancer Mortality in Trials of Heart Failure With Reduced Ejection Fraction: A Systematic Review and Meta-Analysis 131
P38 MAPK and JNK antagonistically control senescence and cytoplasmic p16ink4a expression in doxorubicin-treated endothelial progenitor cells 130
Modes of death and prognostic outliers in chronic heart failure 128
Human amniotic fluid stem cell secretome protects cardiomyocytes against doxorubicin toxicity 128
Brugada syndrome and syncope: a practical approach for diagnosis and treatment 127
Lower mitochondrial energy production of the thigh muscles in patients with low-normal ankle-brachial index 125
Impact of Central Obesity on the Estimation of Carotid-Femoral Pulse Wave Velocity. 125
Metabolic and densitometric correlation between atherosclerotic plaque and trabecular bone: an 18F-Natrium-Fluoride PET/CT study 124
Prevalence, clinical correlates, and functional impact of subaortic ventricular septal bulge (from the Baltimore Longitudinal Study of Aging). 121
Diagnostic and Therapeutic Gaps in Patients With Heart Failure and Chronic Obstructive Pulmonary Disease 121
Indoxyl sulfate: A candidate target for the prevention and treatment of cardiovascular disease in chronic kidney disease 116
Impact of bioprosthetic valve type on peri-procedural myocardial injury and mortality after transcatheter aortic valve replacement 116
Relationship between inter-arm difference in systolic blood pressure and arterial stiffness in community-dwelling older adults. 115
Letter regarding the article 'Heart failure with preserved ejection fraction: from mechanisms to therapies' by Lam and colleagues 114
Relationship between vitamin D status and left ventricular geometry in a healthy population: results from the Baltimore Longitudinal Study of Aging 114
Bmi and acute kidney injury post transcatheter aortic valve replacement: Unveiling the obesity paradox 114
Longitudinal Association between Serum Uric Acid and Arterial Stiffness: Results from the Baltimore Longitudinal Study of Aging 111
Coronary and Cardiac Screening In Liver Transplantation Candidets: A Long Journey with Frequent Identification of Moderate and Severe Coronary Artery Disease 110
Real-world candidacy to mavacamten in a contemporary hypertrophic obstructive cardiomyopathy population 110
[Italian clinical trials on cardiac cell therapy: where we are and where are we going?] 110
Efficacy of new medical therapies in patients with heart failure, reduced ejection fraction and chronic kidney disease already receiving neurohormonal inhibitors: a network meta-analysis 110
Cancer in chronic heart failure patients in the GISSI-HF trial 108
Sometimes they come back: recurrent noncardiac right-to-left shunt after percutaneous patent foramen ovale closure. 107
C–REACTIVE PROTEIN AS A PREDICTOR OF INTIMAL MEDIA THICKNESS IN A HEALTHY COMMUNITY DWELLING POPULATION OF A BROAD AGE RANGE 107
The impossible quest to make cardiac amyloidosis diagnosis easy 104
Pulse wave velocity testing in the Baltimore longitudinal study of aging. 102
Testing longitudinal data for prognostication in ambulatory heart failure patients with reduced ejection fraction. A proof of principle from the GISSI-HF database 102
Mechanical circulatory support in patients with cardiogenic shock not secondary to cardiotomy: a network meta-analysis 100
Cardiac amyloidosis: a changing epidemiology with open challenges 99
Arterial thrombo-embolic events in cardiac amyloidosis: a look beyond atrial fibrillation 99
Diagnosing Fabry nephropathy: the challenge of multiple kidney disease 98
Clinical and Prognostic Implications of Right Ventricular Uptake on Bone Scintigraphy in Transthyretin Amyloid Cardiomyopathy 98
Very Short vs. Long Dual Antiplatelet Therapy after Second Generation Drug-eluting Stents in 35,785 Patients undergoing Percutaneous Coronary Interventions: a Meta-analysis of Randomised Controlled Trials 94
Echocardiographic Tissue Characterization Using Radiomics in Patients With Transthyretin-Related Cardiac Amyloidosis 93
[Clinical studies of cardiac cell therapy in Italy] 93
Prevalence of transthyretin amyloid cardiomyopathy in male patients who underwent bilateral carpal tunnel surgery: The ACTUAL study 93
Pulmonary and cardiac drugs: clinically relevant interactions 92
Diagnostic pathways to wild-type transthyretin amyloid cardiomyopathy: a multicentre network study 90
Telehealth monitoring for hypertrophic cardiomyopathy and amyloid cardiomyopathy patients: Lessons from the coronavirus disease 2019 lockdown in Italy 88
Duration of dual antiplatelet therapy and subsequent monotherapy type in patients undergoing drug eluting stent implantation: a network Meta-analysis 88
Diagnostic yield and predictive value on left ventricular remodelling of genetic testing in dilated cardiomyopathy 87
Reply: The Barcelona Bio-HF Calculator: A Contemporary Web-Based Heart Failure Risk Score 87
Chronic obstructive pulmonary disease and comorbidities in heart failure: the next frontier of sodium–glucose co-transporter 2 inhibitors? 87
Incidence and determinants of atrial fibrillation in patients with wild-type transthyretin cardiac amyloidosis 86
Effect of statin treatment on arterial stiffness in individuals with newly-diagnosed Heterozygous Familial Hypercholesterolemia. 86
From arterial stiffness to heart failure: Still a long way to go 84
Treating amyloid transthyretin cardiomyopathy: lessons learned from clinical trials 83
ECG/echo indexes in the diagnostic approach to amyloid cardiomyopathy: A head-to-head comparison from the AC-TIVE study 82
Temporal Trend of Age at Diagnosis in Hypertrophic Cardiomyopathy: An Analysis of the International Sarcomeric Human Cardiomyopathy Registry 82
Totale 13.592
Categoria #
all - tutte 53.886
article - articoli 51.200
book - libri 0
conference - conferenze 2.686
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 107.772


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021309 0 0 0 0 0 0 0 0 0 133 83 93
2021/20221.148 31 28 73 106 46 108 63 276 83 117 35 182
2022/20231.246 117 119 24 122 193 186 17 88 201 10 152 17
2023/2024780 34 92 17 108 74 108 49 59 51 29 46 113
2024/20252.611 89 174 59 168 362 271 259 430 134 118 253 294
2025/20264.455 576 262 469 463 556 360 791 228 320 430 0 0
Totale 15.568